Director/PDMR Shareholding

RNS Number : 9136N

GlaxoSmithKline PLC

23 January 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, GSK Consumer Healthcare
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The vesting of an award over 8,994 ADSs made under the GlaxoSmithKline Share Value Plan. Of the vested award, 4,430 ADSs were automatically withheld to meet tax liabilities.
c)	Price(s) and volume(s)	Price(s) Volume(s) $38.70 8,994
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2019-01-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

 

END

 

 

DSHXXLFLKFFBBBZ